A Phase 3 Randomized, Placebo-Controlled, Blinded Study to Investigate the Safety and Efficacy of a Topical Gentamicin-Collagen Sponge in Combination With Systemic Antibiotic Therapy in Diabetic Patients With an Infected Foot Ulcer

Trial Profile

A Phase 3 Randomized, Placebo-Controlled, Blinded Study to Investigate the Safety and Efficacy of a Topical Gentamicin-Collagen Sponge in Combination With Systemic Antibiotic Therapy in Diabetic Patients With an Infected Foot Ulcer

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 24 Mar 2017

At a glance

  • Drugs Gentamicin (Primary) ; Antibacterials
  • Indications Diabetic foot ulcer; Skin and soft tissue infections
  • Focus Registrational; Therapeutic Use
  • Acronyms COACT-2
  • Sponsors Innocoll
  • Most Recent Events

    • 19 Jan 2017 This trial has been completed in Belgium.
    • 05 Jan 2017 This trial has been completed in Austria (end date: 2016-10-03).
    • 24 Dec 2016 This trial has been completed in Netherlands.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top